Business Context and Reporting Period
This Form 6-K filing by GSK plc, dated May 12, 2025, reports a transaction in the company's own shares. The filing covers share repurchase activities executed on May 9, 2025, pursuant to a non-discretionary agreement with Citigroup Global Markets Limited entered into on February 24, 2025.
Key Financial Metrics and Transaction Details
- Shares Purchased (May 9, 2025): 650,432 ordinary shares.
- Price Range: Lowest price paid was 1,368.50 GBp; highest price paid was 1,386.50 GBp.
- Volume-Weighted Average Price (VWAP): 1,379.18 GBp.
- Trading Venue: All transactions occurred on the London Stock Exchange (XLON).
- Treasury Shares Held: Following this purchase, GSK holds 208,928,432 ordinary shares in treasury.
- Shares in Issue: 4,106,327,956 ordinary shares (excluding treasury shares).
- Total Voting Rights: 4,106,327,956.
Material Changes and Program Progress
The reported purchase is part of an ongoing share buyback program. Since the program's inception on February 24, 2025, the company has purchased an aggregate of 39,858,129 ordinary shares. The filing does not provide comparative financial data (revenue, profit, or cash flow) for the period, as it is a transaction-specific report rather than a financial results announcement.
Guidance, Outlook, and Risks
The filing includes a standard cautionary statement regarding forward-looking statements. GSK notes that projections are subject to risks and uncertainties that may cause actual results to differ materially. Specific risk factors are referenced in the company's Annual Report on Form 20-F for 2024 and its Q1 Results for 2025. No new guidance or management commentary regarding operational outlook is provided in this document.
Investor Verification Checklist
- Verify the total number of treasury shares held (208,928,432) against the company's latest capital structure disclosures.
- Confirm the remaining authorization under the buyback program initiated on February 24, 2025.
- Review the referenced "Risk Factors" in the 2024 Form 20-F and Q1 2025 results for context on forward-looking statements.
- Check the total number of voting rights (4,106,327,956) for compliance with FCA Disclosure Guidance and Transparency Rules.